Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 29, Issue 10, Pages 2673-2693Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.01140-08
Keywords
-
Categories
Funding
- NIH [CA100857]
- Department of Defense Breast Cancer Research Program [W81XWH-04-1-0442]
- Susan G. Komen Foundation [BCTR0600484]
- UAB Cancer Center Structural Biology Program
Ask authors/readers for more resources
Proper control of the G(1)/S checkpoint is essential for normal proliferation. The activity of p53 must be kept at a very low level under unstressed conditions to allow growth. Here we provide evidence supporting a crucial role for TopBP1 in actively repressing p53. Depletion of TopBP1 upregulates p53 target genes involved in cell cycle arrest and apoptosis and enhances DNA damage-induced apoptosis. The regulation is mediated by an interaction between the seventh and eighth BRCT domains of TopBP1 and the DNA-binding domain of p53, leading to inhibition of p53 promoter binding activity. Importantly, TopBP1 overexpression is found in 46 of 79 primary breast cancer tissues and is associated with high tumor grade and shorter patient survival time. Overexpression of TopBP1 to a level comparable to that seen in breast tumors leads to inhibition of p53 target gene expression and DNA damage-induced apoptosis and G(1) arrest. Thus, a physiological level of TopBP1 is essential for normal G(1)/S transition, but a pathological level of TopBP1 in cancer may perturb p53 function and contribute to an aggressive tumor behavior.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available